コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tion of islet architecture (ratio of beta to alpha cells).
2 y 50% were ZnT8-negative (14 +/- 1.8% of all alpha-cells).
3 a direct effect of leptin on the pancreatic alpha cell.
4 than those presynaptic to the OFF sustained alpha cell.
5 ch multiple a-cells compete to mate with one alpha-cell.
6 ich can selectively stain glucagon secreting alpha cells.
7 ak, inconsistent connections with ON and OFF alpha cells.
8 ric acid A receptor activation in pancreatic alpha cells.
9 loss of beta cell function and expansion of alpha cells.
10 Z treatment sensitizes release mechanisms of alpha cells.
11 nd ROBO2 receptors were detected in beta and alpha cells.
12 resence of a separate population of Ucn 3(+) alpha cells.
13 ineage in primates, but is also expressed in alpha cells.
14 e antagonistically acting glucagon-producing alpha cells.
15 vel observation that they concomitantly gain alpha cells.
16 ansient RGC type that co-stratifies with OFF Alpha cells.
17 anglion cells of which 3.4% (8,300) comprise alpha cells.
18 cells in the presence of a normal number of alpha cells.
19 less dense F-actin networks than EphA4(+/+) alpha-cells.
20 al generated via beta-cell GDH that inhibits alpha-cells.
21 ease via blockade of NaChs in the pancreatic alpha-cells.
22 ion through IL-6-induced GLP-1 production in alpha-cells.
23 articular inhibiting glucagon secretion from alpha-cells.
24 nown about ATP and its relation to Ca(2+) in alpha-cells.
25 duce the proliferation of glucagon-secreting alpha-cells.
26 +)IL-5(+) and CD4(+)IL-2(+)IL-4(+)IL-5(+)TNF-alpha(+)) cells.
28 reting microarray data from MATa cells, MATa/alpha cells, a starving MATalpha/alpha control, and a me
29 reporter was selectively activated in islet alpha-cells, a process mediated by Isl-1 in overexpressi
30 her this pathway is important for regulating alpha-cell activity and glucagon secretion in human isle
32 ion of beta-cells triggered a suppression of alpha-cell activity via gap junction-dependent activatio
34 RNAs, of which only 7 were expressed more in alpha-cells (alpha-miRNAs) and 134 were expressed more i
35 c deletion of the mTORC1 regulator Raptor in alpha cells (alphaRaptorKO), we showed that mTORC1 signa
36 n hormone glucagon-like peptide 1 (GLP-1) by alpha cells and acts directly on beta cells to stimulate
38 islets and isolated islets from mice; human alpha cells and beta cells were sorted by flow cytometry
41 peptide hormones as follows: glucagon in the alpha cells and glucagon-like peptides (GLP)-1 and -2 in
42 ble hyperglucagonemia from insulin-resistant alpha cells and is prevented by glucagon suppression or
43 ncreatic beta-cells with apparent sparing of alpha cells and leads to the disruption of pancreatic is
45 sive beta cells normally regulate juxtaposed alpha cells and that without intraislet insulin, unregul
46 ial entrainment characteristics of circadian alpha-cell and beta-cell clocks are an important feature
48 ne expression, and functional outputs of the alpha-cell and beta-cell clockworks could be assessed in
49 llel analysis of the molecular properties of alpha-cell and beta-cell oscillators using a mouse model
50 n by two mechanisms, a direct stimulation of alpha-cells and an indirect inhibition via somatostatin
51 s our hypothesis that non-beta-cells such as alpha-cells and delta-cells in adults can regenerate, an
53 However, Grg3 is expressed in fewer nascent alpha-cells and is progressively lost from alpha-cells a
54 xpression, and Grg3(+/-) pancreata have more alpha-cells and more polyhormonal cells, indicating that
55 ed subplasmalemmal translocation of STIM1 in alpha-cells and retranslocation in beta-cells involving
58 oundary method for modeling both a-cells and alpha-cells and their cell shape changes, the extracellu
59 ion into triglycerides as compared with p110-alpha(+/+) cells, and hepatic expression of liver fatty
60 ely restricted to pancreatic islet beta- and alpha-cells, and responsible for zinc accumulation into
62 all, this study supports the hypothesis that alpha cells are an endogenous reservoir of potential new
65 from duct cells and transdifferentiation of alpha-cells are potential contributors to the beta-cell
67 y explain why pancreatic beta cells, but not alpha cells, are targeted by an autoimmune response duri
69 of alpha-cell proliferation and expansion of alpha-cell area, consistent with changes exhibited by en
70 t alpha-cells and is progressively lost from alpha-cells as endocrine cells mature into adulthood.
71 s, with a predominance of glucagon-producing alpha cells at the expense of insulin-producing beta cel
72 rted cells are indistinguishable from native alpha-cells based on ultrastructural morphology and main
73 beta-cells; specifically, glucagon-producing alpha-cells begin producing insulin by a process of repr
75 ncreatic islet, including glucagon secreting alpha-cells, but particularly in insulin-secreting beta-
76 to GLP-1 synthesis in human and mouse islet alpha cells by GS/cAMP/PKA/cAMP-response element-binding
77 tion, Slc30a8 was inactivated selectively in alpha-cells by crossing mice with alleles floxed at exon
78 ogues reveals a positive correlation between alpha-cell [Ca(2+)](i) and secretion at low glucose leve
80 ltage-gated calcium channels is critical for alpha-cell calcium oscillations and glucagon secretion a
81 The recent demonstration that pancreatic alpha cells can be continuously regenerated and converte
83 scence does not alter alpha-cell plasticity: alpha-cells can reprogram to produce insulin from pubert
85 Previous studies have noted the increase of alpha-cell composition in diabetes patients and in anima
86 t abnormal glucagon dynamics, and EphA4(-/-) alpha-cells contain less dense F-actin networks than Eph
87 nt decrease in beta-cells and an increase in alpha-cells containing glucagon and glucagon-like peptid
88 trast, before puberty there is no detectable alpha-cell conversion, although beta-cell reconstitution
89 gher numbers found in male fetuses), whereas alpha cell counts were unaffected, precipitating decreas
91 ression of Ucn 3 in primary and hESC-derived alpha cells demonstrates that human Ucn 3 is not exclusi
92 ants of renin-expressing cells as pancreatic alpha cells despite a lack of active renin expression in
93 riptional and epigenetic derepression of the alpha-cell-determining Arx gene in endocrine progenitors
94 wed that mTORC1 signaling is dispensable for alpha cell development, but essential for alpha cell mat
96 s development, including islet beta-cell and alpha-cell differentiation, from single fetal progenitor
102 that postprandial lipemia induces pancreatic alpha cell dysfunction characteristic of type 2 diabetes
103 etes and, therefore, propose that pancreatic alpha cell dysfunction could be viewed, at least partly,
106 ype 2 diabetes is associated with pancreatic alpha cell dysfunction, characterized by elevated fastin
108 ability of an a-cell to distinguish between alpha-cells either making or not making alpha-factor, an
109 imulation of somatostatin secretion inhibits alpha-cell electrical activity by a paracrine mechanism.
111 igated whether TGR5 activation in pancreatic alpha cells enhances hyperglycemia-induced PC1 expressio
114 ntify that reduced mitochondrial function in alpha-cells exerts potently protective effects on beta-c
115 uman alpha, beta, and acinar cells and found alpha cells exhibit intrinsic phenotypic plasticity asso
116 with exocrine and beta cells, differentiated alpha cells exhibited many more genes bivalently marked
126 y facilitate the generation and expansion of alpha-cells for transdifferentiation into beta-cells and
128 We also examined a naturally proliferating alpha-cell from a healthy adult, for which pathway analy
131 r, mechanisms regulating glucagon action and alpha-cell function and number are incompletely understo
132 rate an inhibitory role of PI3K signaling on alpha-cell function and provide experimental evidence fo
133 k regulation involving amino acids regulates alpha-cell function and secretion, while glucagon, in tu
134 ncretin and beta-cell function and decreased alpha-cell function, and thus lower glucose levels.
143 with a phosphomutant form of Ngn3 increases alpha cell generation, the earliest endocrine cell type
145 uring glucose stimulation and interacts with alpha-cell GHB receptors, thus mediating the suppressive
146 (SST) suppression of hypoglycemia-stimulated alpha-cell glucagon release plays an important role.
148 and shows that UCP2 is necessary for normal alpha-cell glucose sensing and the maintenance of euglyc
151 logy modeling type 2 diabetes, activation of alpha-cell gp130 receptor signaling has deleterious effe
153 In this study, we elucidated the effects of alpha-cell gp130 receptor signaling on glycemic control
154 ling between pancreatic islet beta-cells and alpha-cells has been proposed to play a role in regulati
156 eated with incretin therapy were notable for alpha-cell hyperplasia and glucagon-expressing microaden
157 nockout mice), pancreatic swelling is due to alpha-cell hyperplasia with gross hypersecretion of gluc
158 roliferation and dysplasia and the latter by alpha-cell hyperplasia with the potential for evolution
163 that without intraislet insulin, unregulated alpha cells hypersecrete glucagon, which directly causes
165 practical tool to evaluate and identify live alpha cells in terms of localization, distribution and a
168 e effects of anti-TNF-alpha treatment on TNF-alpha(+) cells in the skin and blood of patients with ps
170 sistent with changes exhibited by endogenous alpha-cells in Gcgr(-/-) and Gcgr(Hep)(-/-) pancreata.
171 ecovery of regulated glucagon secretion from alpha-cells in small pseudoislets depends upon the combi
174 indicate that XBP1 deficiency in pancreatic alpha-cells induces altered insulin signaling and dysfun
175 sing and insulin secretion, as well as islet alpha-cell infiltration, which contribute to reduced glu
176 olazine, via blockade of NaChs in pancreatic alpha-cells, inhibits their electrical activity and redu
177 rglucagonemia has been thought to arise from alpha-cell insensitivity to suppressive effects of gluco
178 dult islet, including the glucagon-producing alpha cells, insulin-producing beta cells, somatostatin-
184 found that GIP induces production of IL6 by alpha cells, leading to islet production of GLP1 and ins
185 glucagon-like peptide (GLP)-1 by L cells and alpha cells, leading to secretion of insulin from beta c
188 f miR-200c, miR-125b or miR-182 in the mouse alpha cell line alphaTC6 decreases the level of cMAF mRN
191 -expressed in either pituitary or pancreatic alpha cell lines, proglucagon processing was preferentia
192 plasma amino acids and their transport into alpha-cells link glucagon receptor blockage to alpha-cel
193 egulators of beta-cell (Pdx1 and Nkx6.1) and alpha-cell (MafB and Arx) formation and function are dow
194 -secreting beta cells and glucagon-secreting alpha cells maintain physiological blood glucose levels,
197 responsible for the regulation of pancreatic alpha cell mass and function are not completely understo
200 the maintenance of pancreatic beta-cell and alpha-cell mass and for glucose-stimulated insulin secre
203 rating leukocyte subtypes, and beta-cell and alpha-cell mass in pancreata recovered from organ donors
206 P-4 inhibitors expand beta-cell mass, reduce alpha-cell mass, and inhibit glucagon secretion in precl
207 mpensatory hyperglucagonemia or expansion of alpha-cell mass, and that it cannot be given to induce s
208 y which signaling through the Gcgr regulates alpha-cell mass, wild-type islets were transplanted into
214 or alpha cell development, but essential for alpha cell maturation during the transition from a milk-
215 se differences in intracellular Zn(2+) among alpha-cells may contribute to the inhibition in glucagon
216 g of Adora1 and loss of Adora1 expression on alpha-cells may explain the hyperglucagonemia observed i
220 ontrols, whereas STZ-associated increases in alpha-cell number and serum glucagon were significantly
223 acrine cells presynaptic to the ON sustained alpha cell of mouse retina provide currents with a highe
229 eceptor (Adora1), is gradually diminished in alpha-cells of NOD mice, autoantibody-positive (AA(+)) a
230 is a 29-amino-acid peptide released from the alpha-cells of the islet of Langerhans, which has a key
232 vealed recombination in approximately 30% of alpha-cells, of which approximately 50% were ZnT8-negati
234 for beta-cells and that the influence of the alpha-cells on (111)In-exendin uptake is negligible.
235 promising initial results, the influence of alpha-cells on the uptake of the radiotracer remains a m
236 xpressing three reporter genes: one labeling alpha cells, one specific for beta cells, and a third mo
237 countered no overt changes in numbers of TNF-alpha(+) cells or signs of apoptosis in lesional psoriat
238 ltrastructural morphology and maintain their alpha-cell phenotype after transplantation in vivo.
239 pathways, can drive pancreatic cells with an alpha-cell phenotype toward a beta-cell-like phenotype.
241 We found that senescence does not alter alpha-cell plasticity: alpha-cells can reprogram to prod
242 diabetogenic role of glucagon released from alpha-cells plays a major role in the etiology of both t
243 have suggested that, under some conditions, alpha cells possess the capacity to transdifferentiate i
246 ep)(-/-) mice exhibited an increased rate of alpha-cell proliferation and expansion of alpha-cell are
247 Identification of novel factors regulating alpha-cell proliferation and mass may facilitate the gen
248 ption of hepatic Gcgr signaling can increase alpha-cell proliferation independent of direct pancreati
250 t mice without increasing glucagon levels or alpha-cell proliferation, underscoring the importance of
254 ormal islet size distributions, beta-cell to alpha-cell ratios, endocrine hormone profiles, and RARbe
255 toration of EphA forward signaling in sorted alpha-cells recapitulates both normal basal glucagon sec
261 e topographic distribution of both total and alpha cells reveal a dual topographic organization of a
264 EN, a negative regulator of this pathway, in alpha-cells show reduced circulating glucagon levels and
267 pha-cells, we created complementary in vivo (alpha-cell-specific XBP1 knockout [alphaXBPKO] mice) and
269 sly been shown to downregulate IL-4R subunit alpha cell surface expression and promote Th1 responses.
270 ptide, and glucagon to examine beta-cell and alpha-cell survival and function in a group of 10 chroni
271 glucagon expression expressed selectively in alpha-cells (TFalpha) is targeted by beta-miRNAs; miR-20
272 ion show heterogeneous uptake of Zn(2+) into alpha-cells that correlates to the known heterogeneities
273 let size and an elevated number of beta- and alpha-cells that resulted in an altered beta-cell-to-alp
275 iency did not impair the natural capacity of alpha-cells to reprogram into insulin production after e
276 urine models of diabetes, glucagon-secreting alpha cells transdifferentiate into insulin-secreting be
278 lls to infection by CVB5 and 4 indicate that alpha cells trigger a more efficient antiviral response
280 ow that glucagon, secreted by the pancreatic alpha cell, up-regulates the expression of its own gene
284 requency distributions for beta cells versus alpha cells was observed, thereby establishing both the
285 Furthermore, TGR5-induced GLP-1 release from alpha cells was via an Epac-mediated PKA-independent mec
287 whereas the effect on electrical activity in alpha-cells was blocked by CYN 154806, an antagonist of
289 FFAR1 is also present on glucagon-secreting alpha-cells, we hypothesized that palmitate simultaneous
290 in highly purified adult glucagon-expressing alpha-cells, we observed surprisingly high insulin mRNA
291 sing enhanced yellow fluorescence protein in alpha cells were used to identify alpha cells within pan
293 found SLIT1 and SLIT3 in both beta cells and alpha cells, whereas SLIT2 was predominantly expressed i
294 by SST receptor type 2 (SSTR2) antagonism of alpha-cells, which relieve SSTR2 inhibition, thereby inc
295 Incubation of mouse and human pancreatic alpha cells with GIP induced their production of IL6, le
296 stituted from dispersed islet cells to study alpha-cells with and without various indirect effects fr
297 ound to be expressed in pancreatic beta- and alpha-cells, with high expression in the hyperplastic al
299 -releasing beta-cells and glucagon-secreting alpha-cells within intact mouse and human pancreatic isl
300 undergo a conversion into glucagon-producing alpha-cells without introduction of any genetic modifica
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。